Treatment with antibiotics capable of inducing prolonged shifts in gut microbiota also influences neuroinflammation and amyloidosis in a APP/PS1 mouse model (Minter et al., 2016), further suggesting a link between microbiota and AD-related pathology. Here, APP is linked to Alzheimer disease.